Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHL0601180	萘二磺酸乙乳胆铵	aclatonium napadisilate	Active ingredient	Chemical Drugs(3.1)	New Drug Application	2007-01-17	安徽省新星药物开发有限责任公司	Anhui New Star Pharmaceutical Development Co Ltd	Certificate Issued	2010-10-28	view
CXHL0601181	萘二磺酸乙乳胆铵胶囊	aclatonium napadisilate	Capsule	Chemical Drugs(3.1)	New Drug Application	2007-01-17	安徽省新星药物开发有限责任公司	Anhui New Star Pharmaceutical Development Co Ltd	Certificate Issued	2010-11-02	view
CXHL0700564	萘二磺乙乳胆铵	aclatonium napadisilate	Active ingredient	Chemical Drugs(3.1)	New Drug Application	2008-02-25	扬子江药业集团江苏海慈生物药业有限公司	Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Co Ltd	Certificate Issued	2009-04-21	view
CXHL0700565	萘二磺乙乳胆铵胶囊	aclatonium napadisilate	Capsule	Chemical Drugs(3.1)	New Drug Application	2008-02-25	扬子江药业集团有限公司	Yangtze River Pharmaceutical (Group) Co Ltd	Certificate Issued	2009-04-21	view
CXHL0900347	萘二磺乙乳胆铵	aclatonium napadisilate	Active ingredient	Chemical Drugs(3.1)	New Drug Application	2009-10-26	扬子江药业集团江苏海慈生物药业有限公司	Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Co Ltd	Certificate Issued	2014-07-02	view
CXHL0900348	萘二磺乙乳胆铵胶囊	aclatonium napadisilate	Capsule	Chemical Drugs(3.1)	New Drug Application	2009-10-26	扬子江药业集团有限公司	Yangtze River Pharmaceutical (Group) Co Ltd	Certificate Issued	2014-07-02	view